The goal of this module is to implement actionable strategies for minimizing and managing cardiometabolic risks associated with BD pharmacotherapy.

Presenter Julie Carbray, PhD, APRN, FPMHNP-BC

The goal of this module is to evaluate the limitations of conventional treatments and the optimal role of newer treatments for BD, based on their proposed MOAs, approved indications, and latest safety/efficacy data.

Presenter Greg Mattingly, MD

The goal of this module is to assess and differentiate between BD-I, BD-II, MDD, and related disorders in accordance with current diagnostic criteria and guidelines. 

Presenter Brooke Kempf, PMHNP-BC

The goal of this module is to describe the clinical implications of the changes in the conceptualization of BD across DSM editions, including the specification of mixed features.

Presenter Julie Carbray, PHD, FPMHNP-BC, PMHCNS-BC, APRN

Presenters Julie Carbray, PHD, FPMHNP-BC, PMHCNS-BC, APRN and Jonathan Meyer, MD